Chlamydia pneumoniae, strain TWAR.
نویسنده
چکیده
A new third species of Chiamydia, called C pneumoniae, has been established for the TWAR organism. We first thought that the new organism belonged to the C psittaci species because it was clearly not a C trachomatis.2’8 Subsequent studies showed that the organism was unique from both currently recognized species.8”#{176}”7”9 Justification for establishing a new species rests primarily on studies of the ultrastructure of the elementary body’#{176}and DNA analysis.”9 The organism also is serologically unique from the C trachomatis species and all C psittaci strains tested.2’8 Ultrastructural studies have shown that C pneumoniae has a pear-shaped elementary body. The cytoplasmic mass is round and there is a large penplasmic space . This is entirely different from the elementary bodies of C trachomatis and C psittaci that are round, dense, and have a narrow or barely discernible periplasmic space . Genetic analysis revealed 10 percent or less DNA relatedness between C pneumoniae and the other two species, while homology among the TWAR strains tested was 94 percent or The restriction endonuclease patterns were similar among C pneumoniae isolates and readily distinguishable from C trachomatis and C psittaci strains.” The C pneumoniae also can be differentiated from the other species by using cloned C pneumoniae restriction fragments or whole chromosomal DNA as probes.”
منابع مشابه
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.
Chlamydia pneumoniae strain TWAR, the new third species of Chlamydia, is a common cause of pneumonia and other acute respiratory tract infections. About 10% of hospitalized and outpatient pneumonia cases have been associated with TWAR infection. TWAR is among the four or five most commonly identified causes of all pneumonia. Most TWAR infections are mild or asymptomatic, but occasionally severe...
متن کاملIn vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin.
متن کاملNasal potentials at high altitude.
Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492–503. 3 Kern DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest 1993; 104: 208–213. 4 Johnston SL, Blasi F, Farrell DJ, Nieman RB. Chlamydia pneumoniae infection in patients with acute exacerbations of asthma: the TELICAST study. A...
متن کاملChlamydia in atherosclerosis.
Among the many theories of the pathogenesis of atherosclerosis has been a possible role for infection. However, the possibility that a viral infection initiates or perpetuates damage to the arterial wall has received less attention than other more widely recognized risk factors. Recently, a newly described Chlamydia species, Chlamydia pneumoniae, strain TWAR,' has been associated with atheroscl...
متن کاملEvidence for Chlamydia pneumoniae of non-human origin.
This paper describes the characterization and taxonomic status of N16, a chlamydial isolate from the respiratory tract of a horse. N16 contains plasmid DNA, has normal elementary body morphology and its inclusions do not stain with iodine. Its major outer-membrane protein (MOMP) gene was completely sequenced and compared with the MOMP genes of Chlamydia pneumoniae, C. psittaci, C. trachomatis a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Chest
دوره 95 3 شماره
صفحات -
تاریخ انتشار 1989